Ankylosing spondyolitis is a chronic progressive disease that affects the spine. Over time the spine loses its natural flexibility and becomes rigid like a bamboo pole. The vertebra begins to fuse together causing in ability to function and decreased range of motion. Not only is range of motion affected, but also the disease results in severe pain both from the growth and fusion of bone, compression of nerves, and the loss of function.
Traditionally spa therapies such as balneotherapy and climatotherapy have been used to decrease pain and improve musculoskeletal function. Balneotherapy involves the use of water, heat, and organic materials such as mud or peat packs or baths, and mineral waters such as those found in natural springs. Climatotherapy involves the use of temperature and water to produce favorable effects.
A study published in the Israel Medical Association Journal investigated the effects of balneotherapy and climatotherapy on Ankylosing spondyolitis (AS). The study enrolled 28 individuals who had been diagnosed with AS. They were given daily spa treatments for 2 weeks then followed for 3 months post treatment. The investigators measured the pain index, AS disease Index, quality of life, and range of motion.
They found that treatment with both the balneotherapy and climatotherapy resulted in positive changes. There was significant improvement in the AS disease index as well as pain perception and range of motion. Although there was no difference in the changes observed between the two treatment types, there was a time dependent difference. Research showed that the longer duration treatments resulted in a greater therapeutic benefit.
The only significant difference between the two therapies was a greater improvement in quality of life reported by participants in the balneotherapy group.
This is a promising early study on the effects of spa therapy for Ankylosing spondyolitis. It supports previous evidence that spa treatments can be used effectively for musculoskeletal conditions, acute and chronic. Larger and more long-term studies are needed to show sustained benefit for those with AS.
Posted by Kristopher Foster on February 22, 2006 09:49 AM
